HEMOSTASIS/COAGULATION ANALYZER MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Hemostasis/Coagulation Analyzer Market, By Product (Clinical Laboratory Analyzers, Reagents, Systems, and Point-of-care Testing Analyzers), By Test (Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Platelet Function Tests, Anti-Factor XA Tests, and Others), By Technology (Optical, Mechanical, Electrochemical, and Others), By End User (Clinical Laboratories, Hospitals, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Apr 2024
Code : CMI6906
Pages :146
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Hemostasis/Coagulation Analyzer Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Market Driver – Increasing Prevalence of Coagulation Disorders

The global prevalence of coagulation disorders has been on the rise over the past few decades. Various chronic medical conditions that impair the body's natural blood clotting processes have become more common worldwide. Inherited bleeding disorders like hemophilia A and B affect over 400,000 people globally and the incidence of acquiring these genetic conditions is going up annually. Moreover, lifestyle-related illnesses such as liver disease, kidney failure, and cancer which disrupt the normal homeostasis of coagulation factors in the bloodstream have witnessed a rise coinciding with changing demographics and risk factors. As these patient populations expand, the need for frequent monitoring and management of their coagulation status will drive greater demand for hemostasis analyzers.

Key Players Insights